Taiwan · Delayed Price · Currency is TWD Synmosa Biopharma Statistics
Total Valuation
TPEX:4114 has a market cap or net worth of TWD 15.16 billion. The enterprise value is 16.29 billion.
| Market Cap | 15.16B |
| Enterprise Value | 16.29B |
Important Dates
The next estimated earnings date is Tuesday, August 11, 2026.
| Earnings Date | Aug 11, 2026 |
| Ex-Dividend Date | Jul 11, 2025 |
Share Statistics
TPEX:4114 has 502.77 million shares outstanding. The number of shares has increased by 7.49% in one year.
| Current Share Class | 502.77M |
| Shares Outstanding | 502.77M |
| Shares Change (YoY) | +7.49% |
| Shares Change (QoQ) | +0.60% |
| Owned by Insiders (%) | 9.38% |
| Owned by Institutions (%) | 6.94% |
| Float | 389.48M |
Valuation Ratios
The trailing PE ratio is 18.79.
| PE Ratio | 18.79 |
| Forward PE | n/a |
| PS Ratio | 2.38 |
| PB Ratio | 1.51 |
| P/TBV Ratio | 1.81 |
| P/FCF Ratio | 55.85 |
| P/OCF Ratio | 33.42 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 15.36, with an EV/FCF ratio of 60.00.
| EV / Earnings | 20.19 |
| EV / Sales | 2.56 |
| EV / EBITDA | 15.36 |
| EV / EBIT | 22.39 |
| EV / FCF | 60.00 |
Financial Position
The company has a current ratio of 2.60, with a Debt / Equity ratio of 0.25.
| Current Ratio | 2.60 |
| Quick Ratio | 1.64 |
| Debt / Equity | 0.25 |
| Debt / EBITDA | 2.36 |
| Debt / FCF | 9.45 |
| Interest Coverage | 12.08 |
Financial Efficiency
Return on equity (ROE) is 6.18% and return on invested capital (ROIC) is 5.86%.
| Return on Equity (ROE) | 6.18% |
| Return on Assets (ROA) | 3.41% |
| Return on Invested Capital (ROIC) | 5.86% |
| Return on Capital Employed (ROCE) | 6.55% |
| Weighted Average Cost of Capital (WACC) | 3.90% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.46 |
| Inventory Turnover | 1.76 |
Taxes
In the past 12 months, TPEX:4114 has paid 190.26 million in taxes.
| Income Tax | 190.26M |
| Effective Tax Rate | 24.10% |
Stock Price Statistics
The stock price has decreased by -3.04% in the last 52 weeks. The beta is 0.00, so TPEX:4114's price volatility has been lower than the market average.
| Beta (5Y) | 0.00 |
| 52-Week Price Change | -3.04% |
| 50-Day Moving Average | 31.01 |
| 200-Day Moving Average | 32.88 |
| Relative Strength Index (RSI) | 33.44 |
| Average Volume (20 Days) | 1,050,283 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:4114 had revenue of TWD 6.37 billion and earned 806.68 million in profits. Earnings per share was 1.60.
| Revenue | 6.37B |
| Gross Profit | 2.73B |
| Operating Income | 756.54M |
| Pretax Income | 789.44M |
| Net Income | 806.68M |
| EBITDA | 1.07B |
| EBIT | 756.54M |
| Earnings Per Share (EPS) | 1.60 |
Balance Sheet
The company has 2.71 billion in cash and 2.57 billion in debt, with a net cash position of 140.69 million or 0.28 per share.
| Cash & Cash Equivalents | 2.71B |
| Total Debt | 2.57B |
| Net Cash | 140.69M |
| Net Cash Per Share | 0.28 |
| Equity (Book Value) | 10.07B |
| Book Value Per Share | 17.51 |
| Working Capital | 3.98B |
Cash Flow
In the last 12 months, operating cash flow was 453.62 million and capital expenditures -182.20 million, giving a free cash flow of 271.43 million.
| Operating Cash Flow | 453.62M |
| Capital Expenditures | -182.20M |
| Depreciation & Amortization | 312.15M |
| Net Borrowing | -112.96M |
| Free Cash Flow | 271.43M |
| FCF Per Share | 0.54 |
Margins
Gross margin is 42.84%, with operating and profit margins of 11.88% and 12.66%.
| Gross Margin | 42.84% |
| Operating Margin | 11.88% |
| Pretax Margin | 12.39% |
| Profit Margin | 12.66% |
| EBITDA Margin | 16.78% |
| EBIT Margin | 11.88% |
| FCF Margin | 4.26% |
Dividends & Yields
This stock pays an annual dividend of 0.85, which amounts to a dividend yield of 2.82%.
| Dividend Per Share | 0.85 |
| Dividend Yield | 2.82% |
| Dividend Growth (YoY) | 9.82% |
| Years of Dividend Growth | 5 |
| Payout Ratio | 33.79% |
| Buyback Yield | -7.49% |
| Shareholder Yield | -4.66% |
| Earnings Yield | 5.32% |
| FCF Yield | 1.79% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on July 11, 2025. It was a forward split with a ratio of 1.099848595.
| Last Split Date | Jul 11, 2025 |
| Split Type | Forward |
| Split Ratio | 1.099848595 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |